Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.03.23.644843

Pharmacological inhibition of mitochondrial fission mitigates experimental thoracic aortic aneurysm

Abstract

Thoracic aortic aneurysm (TAA) is increasingly recognized as a vascular degenerative disease and is typically diagnosed incidentally due to its asymptomatic nature. TAA is clinically associated with the dilation of the aorta and excessive vascular remodeling, which can lead to aortic rupture if left untreated. Angiotensin II (Ang II), an active peptide in the renin-angiotensin system, has been widely implicated in the development of TAA. The current study investigated the role of mitochondrial dynamics in the onset and progression of TAA. Male ApoEKO mice (8-10 weeks old) were infused with Ang II (1.44 mg/kg/day) and treated with mitochondrial division inhibitor 1 (mdivi-1) at a dose of 0.12 mg/kg/day. After 4 weeks of Ang II infusion, the ApoEKO mice developed TAA. Excessive mitochondrial fission was observed in thoracic vascular smooth muscle cells (vSMCs) using transmission electron microscopy (TEM) and confocal microscopy in response to angiotensin II (Ang II) treatment, which was reduced by mdivi-1. Echocardiographic and histological analyses of the Ang II-infused thoracic aorta revealed increased aortic dilation, vascular remodeling, and perivascular fibrosis. Pathological changes associated with Ang II-induced TAA were mitigated by mdivi-1. Co-treatment of isolated adult murine thoracic aortic vSMCs with mdivi-1 resulted in decreased mitochondrial fission, hyperproliferation, and phenotypic switching, accompanied by improved mitochondrial metabolism. Treatment with mdivi-1 inhibited Ang II-induced NF-{kappa}B signaling in vSMCs by blocking the nuclear translocation of p65 and cell cycle markers, thereby limiting inflammation and hyperproliferation. In conclusion, the inhibition of mitochondrial fission reduced pathological changes by mitigating vascular remodeling, vSMC hyperproliferation, and vSMC phenotypic switching associated with Ang II-induced TAA. The clinical utility of inhibiting mitochondrial fission warrants further investigation, which may lead to a novel therapeutic strategy for preventing TAA development.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jadli, A. S., Gomes, K. P., Meechem, M., Mackay, C., Ballasy, N. N., Belke, D. D., Fedak, P. W., Patel, V. B.. 2025-03-25. Pharmacological inhibition of mitochondrial fission mitigates experimental thoracic aortic aneurysm. https://doi.org/10.1101/2025.03.23.644843

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Hypothalamic Farnesoid X Receptor deficiency alters energy balance by modulating hepatic glucose production and adipose tissue metabolism through central insulin signaling.

Objectives: The bile acid nuclear receptor Farnesoid X Receptor (FXR, NR1H4) is a major regulator of metabolism and energy homeostasis in peripheral organs. It modulates bile acid, glucose, and lipid metabolism, as well as fat mass and body weight. However, FXR is also expressed in the brain, particularly in the hypothalamus, a key center for the regulation of energy homeostasis. Although one study has demonstrated a role for brain FXR activation in energy balance, its specific hypothalamic role is still unknown. Here, we examined the role of FXR in the mediobasal hypothalamus in the regulation of energy balance. Methods: We used a genetic approach combined with metabolic phenotyping to determine the effect of FXR invalidation in the mediobasal hypothalamus on metabolic parameters involved in the central regulation of energy homeostasis. Results: Our results demonstrate that hypothalamic FXR deficiency induces a positive energy balance, resulting in a reduction in energy expenditure due to alterations in glucose metabolism accompanied by structural changes in white adipose tissues. Conclusion: This study uncovers a previously unrecognized role for hypothalamic FXR in the central homeostatic control of energy balance, providing new insights into its contribution to peripheral glucose metabolism and adipose tissue structural remodeling.

physiology↗

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗

Light-cycle time-restricted feeding remodels a hidden layer of the cardiac transcriptome through sex-specific transcript switching

Light-cycle time-restricted feeding disrupts daily cardiovascular and thermoregulatory rhythms, but the molecular effects of light-cycle time-restricted feeding on the heart have been measured only at the level of total gene expression. We used Oxford Nanopore long-read RNA sequencing to resolve the full-length ventricular transcriptome from male and female mice under ad libitum feeding or light-cycle time-restricted feeding across the 24-hour cycle. Greater than 20% of cardiac transcripts represent unannotated variants of known genes absent from the current GENCODE reference annotation. Light-cycle time-restricted feeding reorganizes transcript usage across hundreds of genes, including genes encoding splicing regulators, largely without changing total gene expression. The genes affected are sex-specific, with fewer than 2% of changes shared at the gene, transcript, and transcript-usage levels. We show that transcript-level regulation is a previously underrecognized component of the cardiac response to altered feeding behavior, undetected by conventional short-read approaches.

physiology↗